Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chinese CRO Alliance Sets Eyes On Europe

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - U.K.-based NovaSecta joined Sundia Meditech and HD Biosciences in China's first contract research organization alliance, the three companies announced Feb. 18

You may also be interested in...



China's Largest Science Park Aims To Double Pharma Output In Three Years; Launches New Partnering Platform

SHANGHAI - The pharmaceutical output of Shanghai Pudong area, where the Zhangjiang Hi-tech park is located, achieved RMB 12.7 billion ($1.85 billion) in 2008 and increased 13.1 percent compared to 2007, said Lin Benchun, the deputy chief of Shanghai Pudong Science and Technology Commission, during the China Pharmaceutical R&D Summit preconference April 6

China's Largest Science Park Aims To Double Pharma Output In Three Years; Launches New Partnering Platform

SHANGHAI - The pharmaceutical output of Shanghai Pudong area, where the Zhangjiang Hi-tech park is located, achieved RMB 12.7 billion ($1.85 billion) in 2008 and increased 13.1 percent compared to 2007, said Lin Benchun, the deputy chief of Shanghai Pudong Science and Technology Commission, during the China Pharmaceutical R&D Summit preconference April 6

AstraZeneca Outsources Drug Discovery Research To BioDuro For Respiratory And Inflammation Indications

SHANGHAI - AstraZeneca is expanding its research collaboration with contract research organization BioDuro to cooperate on drug discovery research in respiratory and inflammation diseases in China, the two companies announced March 23

Related Content

UsernamePublicRestriction

Register

MT125590

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel